A drug-containing capsule (20, 30, 40) includes a capsule material (21, 31, 41) and a drug (22, 32, 42) disposed within the capsule material (21, 31, 41) and having a sterilization action for a specific microorganism. The capsule material (21, 31, 41) includes a degradable part (21a, 31a, 41a) formed of a raw material that is caused to biodegrade by the specific microorganism. This results in suppression of release of the drug while the specific microorganism does not proliferate.

A new synthesized non-peptide cationic oligo-guanidinium dendrimers containing a number of positive charges, 6, 9, 12, and 18 for use as antimicrobial agents and a method for synthesizing non-peptide cationic oligo-guanidinium dendrimers G12 and G18. These designed and synthesized dendrimers exhibit antimicrobial activities as well as biofilm disrupting activity against various pathogens such as Gram-negative bacteria, Gram-positive bacteria, and fungi. The application of these dendrimers are very broad, which includes application to pharmaceutical compounds that are covalently or non-covalently complexed. These combinations are important in helping the body reach the proper immune balance required for maximized function and/or optimal health.

A new synthesized non-peptide cationic oligo-guanidinium dendrimers containing a number of positive charges, 6, 9, 12, and 18 for use as antimicrobial agents and a method for synthesizing non-peptide cationic oligo-guanidinium dendrimers G12 and G18. These designed and synthesized dendrimers exhibit antimicrobial activities as well as biofilm disrupting activity against various pathogens such as Gram-negative bacteria, Gram-positive bacteria, and fungi. The application of these dendrimers are very broad, which includes application to pharmaceutical compounds that are covalently or non-covalently complexed. These combinations are important in helping the body reach the proper immune balance required for maximized function and/or optimal health.

The present disclosure concerns methods of using novel bacterial strains of 0617-T307, 0917-T305, 0917-T306, 0917-T307, 0118-T319, 0318-T327, and 0418-T328, the cell broth and novel metabolites produced from the bacterial strains, that can inhibit the growth of a variety of microbial species for a variety of crops. The methods include use of novel, potent antimicrobial metabolites produced from the strains corresponding to compounds having Formulas (I), (II), and (III): ##STR00001##

A method for producing mesoporous magnesium hydroxide nanoplates involving solvothermal treatment of a solution of a magnesium salt, a base, a glycol, and water is disclosed. The method does not use a surfactant or template in the solvothermal treatment. The method yields mesoporous nanoparticles of magnesium hydroxide having a plate-like morphology with a diameter of 20 nm to 100 nm, a mean pore diameter of 2 to 10 nm, a surface area of 50 to 70 m.sup.2/g, and a type-III nitrogen adsorption-desorption BET isotherm with a H3 hysteresis loop. An antibacterial composition containing the mesoporous magnesium hydroxide nanoplates is also disclosed. A method for reducing nitroaromatic compounds with a reducing agent and the mesoporous magnesium hydroxide nanoplates as a catalyst is also disclosed.

Use of brown melanoidins in compositions and methods to protect plants against a wide variety of non-fungal pests is disclosed. In some exemplary embodiments of the invention, the plants are nightshades, for example tomato. In some exemplary embodiments of the invention, the plants are cucurbits, for example cucumber. Alternatively or additionally, in some embodiments the pests are selected from the group consisting of viruses, bacteria, oomycetes, and arthropods.

Use of brown melanoidins in compositions and methods to protect plants against a wide variety of non-fungal pests is disclosed. In some exemplary embodiments of the invention, the plants are nightshades, for example tomato. In some exemplary embodiments of the invention, the plants are cucurbits, for example cucumber. Alternatively or additionally, in some embodiments the pests are selected from the group consisting of viruses, bacteria, oomycetes, and arthropods.

It is an object of the present invention to provide a solid drug that is very convenient to transport and store. In order to achieve the object, a drug according to the present invention is a solid drug that includes a radical generating catalyst and a radical generation source.

Disclosed herein are methods for inhibiting pathogenic infection and inhibiting growth of pathogens using a conductive polymer material including a conductive component. The conductive component contains poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate), and a molar ratio of poly(3,4-ethylenedioxythiophene) to poly(styrenesulfonate) in the poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate) ranges from 1:1 to 1:25.

Disclosed herein are methods for inhibiting pathogenic infection and inhibiting growth of pathogens using a conductive polymer material including a conductive component. The conductive component contains poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate), and a molar ratio of poly(3,4-ethylenedioxythiophene) to poly(styrenesulfonate) in the poly(3,4-ethylenedioxythiophene)-poly(styrenesulfonate) ranges from 1:1 to 1:25.